Class information for:
Level 1: LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
22911 308 26.5 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
708 12194 CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LERCANIDIPINE Author keyword 69 58% 26% 79
2 LACIDIPINE Author keyword 42 42% 25% 78
3 LERCANIDIPINE HYDROCHLORIDE Author keyword 8 62% 3% 8
4 HYDROCHLOROTHIAZIDE HCTZ Author keyword 2 67% 1% 2
5 CAS 132866 11 6 Author keyword 1 100% 1% 2
6 IL DRUG DISCOVERY NEW CHEM ENTITIES DEV Address 1 50% 1% 2
7 REC 15 2375 PHARMACOLOGY Author keyword 1 100% 1% 2
8 MANIDIPINE Author keyword 1 11% 2% 6
9 24 HOUR BP PATTERN Author keyword 1 50% 0% 1
10 ACUTE DOSING Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LERCANIDIPINE 69 58% 26% 79 Search LERCANIDIPINE Search LERCANIDIPINE
2 LACIDIPINE 42 42% 25% 78 Search LACIDIPINE Search LACIDIPINE
3 LERCANIDIPINE HYDROCHLORIDE 8 62% 3% 8 Search LERCANIDIPINE+HYDROCHLORIDE Search LERCANIDIPINE+HYDROCHLORIDE
4 HYDROCHLOROTHIAZIDE HCTZ 2 67% 1% 2 Search HYDROCHLOROTHIAZIDE+HCTZ Search HYDROCHLOROTHIAZIDE+HCTZ
5 CAS 132866 11 6 1 100% 1% 2 Search CAS+132866+11+6 Search CAS+132866+11+6
6 REC 15 2375 PHARMACOLOGY 1 100% 1% 2 Search REC+15+2375++PHARMACOLOGY Search REC+15+2375++PHARMACOLOGY
7 MANIDIPINE 1 11% 2% 6 Search MANIDIPINE Search MANIDIPINE
8 24 HOUR BP PATTERN 1 50% 0% 1 Search 24+HOUR+BP+PATTERN Search 24+HOUR+BP+PATTERN
9 ACUTE DOSING 1 50% 0% 1 Search ACUTE+DOSING Search ACUTE+DOSING
10 CA2 CHANNEL BLOCKERS CCBS 1 50% 0% 1 Search CA2+CHANNEL+BLOCKERS+CCBS Search CA2+CHANNEL+BLOCKERS+CCBS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LACIDIPINE 8 34% 6% 19
2 LERCANIDIPINE 6 41% 4% 11
3 RADIOIMMUNOASSAY METHOD 6 100% 1% 4
4 REC 15 2375 4 75% 1% 3
5 LEG EDEMA 1 17% 3% 8
6 1 4 DIHYDROPYRIDINE CALCIUM ANTAGONIST 1 100% 1% 2
7 5 1 4 DIHYDROPYRIDINES 1 100% 1% 2
8 CHROMATOGRAPHIC RADIOIMMUNOASSAY METHOD 1 100% 1% 2
9 OLMESARTAN HYDROCHLOROTHIAZIDE COMBINATION 1 40% 1% 2
10 CALCIUM ANTAGONIST LERCANIDIPINE 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence 2012 7 49 33%
Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? 2009 8 26 65%
Results of a Meta-Analysis Comparing the Tolerability of Lercanidipine and Other Dihydropyridine Calcium Channel Blockers 2009 16 20 40%
Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: The TOLERANCE study 2008 6 20 85%
Lercanidipine - A review of its efficacy in the management of hypertension 2003 45 42 57%
LACIDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF HYPERTENSION 1994 39 69 54%
Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers 2003 10 6 83%
Renal protection with calcium antagonists: the role of lercanidipine 2013 2 25 20%
Third Generation Calcium Antagonist Lercanidipine: the Evidence Base for Clinical Decision 2014 0 19 68%
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure 2011 8 24 21%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 IL DRUG DISCOVERY NEW CHEM ENTITIES DEV 1 50% 0.6% 2
2 BIOEQUIVALENCE PHARMACEUT STUDIES 1 50% 0.3% 1
3 CARDIOL NUTR 1 50% 0.3% 1
4 CARDIOVASC PATHOPHYSIOL IMAGING 1 50% 0.3% 1
5 CS ROSA LUXEMBURGO 1 50% 0.3% 1
6 DIPARTIMENTO MED CLIN BIOTECHNOL PLICATA D CA 1 50% 0.3% 1
7 ENGN CHEM MAT XINJIANG BINGTUAN 1 50% 0.3% 1
8 FRANZ VOLLHARD CLIN 1 50% 0.3% 1
9 FREMANTLE HOSP MED PHARMACOL 1 50% 0.3% 1
10 GLAXO WELLCOME SPA 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000239571 MEBUDIPINE//BARNIDIPINE HYDROCHLORIDE//BARNIDIPINE
2 0.0000232925 AMLODIPINE//DILTIAZEM CR//BESYLATE
3 0.0000163241 FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE
4 0.0000155248 ANTIOXIDANT PHARMACOL//NITROSONIFEDIPINE//MYOCYTE MIGRATION
5 0.0000140664 AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY
6 0.0000121629 CILNIDIPINE//BENIDIPINE//AZELNIDIPINE
7 0.0000091549 HYDROCHLOROTHIAZIDE//AMLODIPINE BESYLATE//LOSARTAN POTASSIUM
8 0.0000090670 ISRADIPINE//CAS 75695 93 1//DENSITY DEPENDENT GROWTH INHIBITION
9 0.0000087852 DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER//ETAFTORON//HOSP XIAMEN AFFILIATED 1
10 0.0000084065 BLOOD FLOW ACCELERATION//EQUIPMENT AUTOMATIC BLOOD PRESSURE//STRAIN GAUGE VENOUS PLETHYSMOGRAPHY